Article Text

PDF
Sequential therapy for H. pylori eradication
  • Relevant BNF section: BNF 1.3

Abstract

Helicobacter pylori eradication therapy helps to prevent recurrence of, and re-bleeding from, gastric and duodenal ulcers. It also causes regression of most localised gastric mucosa-associated lymphoid-tissue (MALT) lymphomas.1 Standard triple therapy (comprising a proton pump inhibitor [PPI] plus two antibacterials) has been used routinely to eradicate H. pylori.2,3 However, the effectiveness of this type of regimen has declined over time, mainly due to antibacterial resistance.2,3 Consequently, other regimens are being used, and these include sequential therapy (e.g. a PPI plus amoxicillin, followed by a PPI plus two other antibacterials).3 Here we assess the efficacy and safety of sequential H. pylori eradication therapy.

Statistics from Altmetric.com

  • Relevant BNF section: BNF 1.3

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.